FNTN.DEFNTN.DEXETRA
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+14.3%
5Y CAGR+10.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+14.3%/yr
vs +5.9%/yr prior
5Y CAGR
+10.7%/yr
Recent acceleration
Acceleration
+8.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.42 | +7.3% |
| 2024 | 1.32 | +15.2% |
| 2023 | 1.15 | +20.7% |
| 2022 | 0.95 | -14.7% |
| 2021 | 1.11 | +30.9% |
| 2020 | 0.85 | -4.6% |
| 2019 | 0.89 | +18.2% |
| 2018 | 0.75 | -33.4% |
| 2017 | 1.13 | +11.3% |
| 2016 | 1.02 | - |